Baptist Health Lexington introduces Aquablation therapy for treatment of BPH

LEXINGTON, KY (Aug. 10, 2023) – Baptist Health Lexington now offers Aquablation therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).

BPH, or an enlarged prostate, is a non-cancerous condition where the prostate has grown to cause obstruction of the bladder. One in two men ages 51 to 60 have BPH, and the incidence increases every decade of life. If left untreated, BPH can cause significant health problems, including irreversible bladder or kidney damage, bladder stones, and incontinence.

Aquablation therapy combines real-time, multi-dimensional imaging, automated robotics, and heat-free waterjet ablation for targeted, controlled, and immediate removal of prostate tissue. Surgeons can create a personalized treatment plan tailored to each patient’s anatomy.

“There are no incisions for this procedure and the heat-free robotically controlled waterjet allows us great precision when removing excess tissue, with a lower risk of harming the remaining prostate tissue, avoiding critical structures to preserve sexual function and continence,” said Amul Bhalodi, MD, a urologist at Baptist Health Lexington who was one of the first physicians in the region to utilize Aquablation therapy.

Current BPH surgical treatments for enlarged prostates can have significant side effects such as incontinence and erectile dysfunction. These side effects can be mitigated with the use of personalized treatment plans based on the patient’s symptoms and anatomy.

For more information about services offered at Baptist Health Lexington visit Baptisthealthlexington.com.